Literature DB >> 34031032

High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases.

Jake A Ruddy1,2, Caoilfhionn Marie Connolly2, Brian J Boyarsky1, William A Werbel3, Lisa Christopher-Stine2, Jacqueline Garonzik-Wang1, Dorry L Segev4,5, Julie J Paik2.   

Abstract

Entities:  

Keywords:  COVID-19; autoimmune diseases; epidemiology; vaccination

Mesh：

Substances：

Year:  2021        PMID： 34031032      PMCID： PMC8843949          DOI： 10.1136/annrheumdis-2021-220656

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort.

Authors:  Ulf M Geisen; Dennis K Berner; Florian Tran; Melike Sümbül; Lena Vullriede; Maria Ciripoi; Hayley M Reid; Annika Schaffarzyk; Ann C Longardt; Jeanette Franzenburg; Paula Hoff; Jan H Schirmer; Rainald Zeuner; Anette Friedrichs; Andrea Steinbach; Christine Knies; Robert Dh Markewitz; Peter J Morrison; Sascha Gerdes; Stefan Schreiber; Bimba F Hoyer
Journal:  Ann Rheum Dis       Date:  2021-03-24       Impact factor: 19.103

2.  Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series.

Authors:  Caoilfhionn M Connolly; Brian J Boyarsky; Jake A Ruddy; William A Werbel; Lisa Christopher-Stine; Jacqueline M Garonzik-Wang; Dorry L Segev; Julie J Paik
Journal:  Ann Intern Med       Date:  2021-05-25       Impact factor: 25.391

3.  Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.

Authors:  Brian J Boyarsky; Jake A Ruddy; Caoilfhionn M Connolly; Michael T Ou; William A Werbel; Jacqueline M Garonzik-Wang; Dorry L Segev; Julie J Paik
Journal:  Ann Rheum Dis       Date:  2021-03-23       Impact factor: 27.973

4.  Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.

Authors:  Alicia T Widge; Nadine G Rouphael; Lisa A Jackson; Evan J Anderson; Paul C Roberts; Mamodikoe Makhene; James D Chappell; Mark R Denison; Laura J Stevens; Andrea J Pruijssers; Adrian B McDermott; Britta Flach; Bob C Lin; Nicole A Doria-Rose; Sijy O'Dell; Stephen D Schmidt; Kathleen M Neuzil; Hamilton Bennett; Brett Leav; Mat Makowski; Jim Albert; Kaitlyn Cross; Venkata-Viswanadh Edara; Katharine Floyd; Mehul S Suthar; Wendy Buchanan; Catherine J Luke; Julie E Ledgerwood; John R Mascola; Barney S Graham; John H Beigel
Journal:  N Engl J Med       Date:  2020-12-03       Impact factor: 91.245

5.  Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation.

Authors:  Victoria Higgins; Anselmo Fabros; Vathany Kulasingam
Journal:  J Clin Microbiol       Date:  2021-03-19       Impact factor: 5.948

6.  Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.

Authors:  Edward E Walsh; Robert W Frenck; Ann R Falsey; Nicholas Kitchin; Judith Absalon; Alejandra Gurtman; Stephen Lockhart; Kathleen Neuzil; Mark J Mulligan; Ruth Bailey; Kena A Swanson; Ping Li; Kenneth Koury; Warren Kalina; David Cooper; Camila Fontes-Garfias; Pei-Yong Shi; Özlem Türeci; Kristin R Tompkins; Kirsten E Lyke; Vanessa Raabe; Philip R Dormitzer; Kathrin U Jansen; Uğur Şahin; William C Gruber
Journal:  N Engl J Med       Date:  2020-10-14       Impact factor: 91.245
  6 in total
  43 in total

1.  Attenuated response to fourth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series.

Authors:  Mayan Teles; Caoilfhionn M Connolly; Sarah Frey; Teresa Po-Yu Chiang; Jennifer L Alejo; Brian J Boyarsky; Ami A Shah; Jemima Albayda; Lisa Christopher-Stine; William A Werbel; Dorry L Segev; Julie J Paik
Journal:  Ann Rheum Dis       Date:  2022-01-17       Impact factor: 19.103

2. 

Authors:  Maxime Auroux; Benjamin Laurent; Baptiste Coste; Emmanuel Massy; Alexandre Mercier; Isabelle Durieu; Cyrille B Confavreux; Jean-Christophe Lega; Sabine Mainbourg; Fabienne Coury
Journal:  Rev Rhum Ed Fr       Date:  2022-07-08

3.  Evaluation of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Levels in Coronavirus Disease Breakthrough Infection During Immunosuppressive Therapy in a Patient with Connective Tissue Disease-Related Interstitial Lung Disease.

Authors:  Takuma Tsuzuki Wada; Kazuhiro Yokota; Sakon Sakai; Machika Soma; Hiroshi Kajiyama; Norihito Tarumoto; Shigefumi Maesaki; Takuya Maeda; Makoto Nagata; Toshihide Mimura
Journal:  Mod Rheumatol Case Rep       Date:  2022-06-22

4.  COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication.

Authors:  Tiago Azenha Rama; Joana Miranda; Diana Silva; Luís Amaral; Eunice Castro; Alice Coimbra; André Moreira; José Luís Plácido
Journal:  Vaccines (Basel)       Date:  2022-05-04

5.  Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort.

Authors:  Daniele Mauro; Antonio Ciancio; Claudio Di Vico; Luana Passariello; Gelsomina Rozza; Maria Dora Pasquale; Ilenia Pantano; Carlo Cannistrà; Laura Bucci; Silvia Scriffignano; Flavia Riccio; Martina Patrone; Giuseppe Scalise; Piero Ruscitti; Maria Vittoria Montemurro; Antonio Giordano; Maria Teresa Vietri; Francesco Ciccia
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

6.  Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases.

Authors:  Napaporn Chantasrisawad; Thanyawee Puthanakit; Auchara Tangsathapornpong; Chonnamet Techasaensiri; Wanatpreeya Phongsamart; Detchvijitr Suwanpakdee; Peera Jaruampornpan; Jiratchaya Sophonphan; Piyarat Suntarattiwong; Tawee Chotpitayasunondh
Journal:  Vaccines (Basel)       Date:  2022-05-29

7.  Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021.

Authors:  Nathaniel M Lewis; Eric A Naioti; Wesley H Self; Adit A Ginde; David J Douin; H Keipp Talbot; Jonathan D Casey; Nicholas M Mohr; Anne Zepeski; Manjusha Gaglani; Shekhar A Ghamande; Tresa A McNeal; Nathan I Shapiro; Kevin W Gibbs; D Clark Files; David N Hager; Arber Shehu; Matthew E Prekker; Heidi L Erickson; Michelle N Gong; Amira Mohamed; Daniel J Henning; Jay S Steingrub; Ithan D Peltan; Samuel M Brown; Emily T Martin; Kinsley Hubel; Catherine L Hough; Laurence W Busse; Caitlin C Ten Lohuis; Abhijit Duggal; Jennifer G Wilson; Alexandra J Gordon; Nida Qadir; Steven Y Chang; Christopher Mallow; Carolina Rivas; Hilary M Babcock; Jennie H Kwon; Matthew C Exline; Natasha Halasa; James D Chappell; Adam S Lauring; Carlos G Grijalva; Todd W Rice; Jillian P Rhoads; William B Stubblefield; Adrienne Baughman; Kelsey N Womack; Christopher J Lindsell; Kimberly W Hart; Yuwei Zhu; Stephanie J Schrag; Miwako Kobayashi; Jennifer R Verani; Manish M Patel; Mark W Tenforde
Journal:  J Infect Dis       Date:  2022-05-16       Impact factor: 7.759

8.  Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series.

Authors:  Ting Zhao; Jiayan Shen; Youyang Zhu; Xiaofang Tian; Guangfen Wen; Yuanyuan Wei; Bonan Xu; Chenyang Fu; Zhaohu Xie; Yujiang Xi; Zhenmin Li; Jiangyun Peng; Yang Wu; Xiaohu Tang; Chunping Wan; Lei Pan; Zhaofu Li; Dongdong Qin
Journal:  Front Public Health       Date:  2022-04-25

9.  Impact of methotrexate on first-dose COVID-19 mRNA vaccination.

Authors:  Caoilfhionn M Connolly; Julie J Paik
Journal:  Lancet Rheumatol       Date:  2021-07-08

10.  Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.

Authors:  Jennifer R Verani; Wesley H Self; Mark W Tenforde; Manish M Patel; Adit A Ginde; David J Douin; H Keipp Talbot; Jonathan D Casey; Nicholas M Mohr; Anne Zepeski; Manjusha Gaglani; Tresa McNeal; Shekhar Ghamande; Nathan I Shapiro; Kevin W Gibbs; D Clark Files; David N Hager; Arber Shehu; Matthew E Prekker; Heidi L Erickson; Matthew C Exline; Michelle N Gong; Amira Mohamed; Daniel J Henning; Jay S Steingrub; Ithan D Peltan; Samuel M Brown; Emily T Martin; Arnold S Monto; Akram Khan; C Terri Hough; Laurence Busse; Caitlin C Ten Lohuis; Abhijit Duggal; Jennifer G Wilson; Alexandra June Gordon; Nida Qadir; Steven Y Chang; Christopher Mallow; Hayley B Gershengorn; Hilary M Babcock; Jennie H Kwon; Natasha Halasa; James D Chappell; Adam S Lauring; Carlos G Grijalva; Todd W Rice; Ian D Jones; William B Stubblefield; Adrienne Baughman; Kelsey N Womack; Christopher J Lindsell; Kimberly W Hart; Yuwei Zhu; Samantha M Olson; Meagan Stephenson; Stephanie J Schrag; Miwako Kobayashi
Journal:  medRxiv       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.